Richard Whitley

Richard J.
Whitley is the founder of Immvira Bioscience, Inc. (2015) and Treovir Inc (2019).
Dr. Whitley is also the founder of Alabama Drug Discovery Alliance.
Current jobs include Director at Primus Pharmaceuticals, Inc., Director at FermaVir Pharmaceuticals LLC, Co-Director-Pediatric Infectious Diseases at Washington University School of Medicine, Independent Director at Dogwood Therapeutics, Inc., Member at Association of American Physicians, Member at American Society of Clinical Investigation, Professor at The University of Alabama at Birmingham, and Member-Supervisory Board at Leyden Laboratories BV.
Former jobs include Chairman-Scientific Councilors at Centers for Disease Control & Prevention (2000-2012), Chairman-HIV Vaccine Data Safety at National Institute of Allergy & Infectious Diseases, Independent Director at Gilead Sciences, Inc. (2008-2021), Director at Gilead Connecticut, Inc., Independent Director at Virios Therapeutics, Inc., President at Infectious Diseases Society of America, and President at The International Society for Antiviral Research.
Education includes undergraduate and doctorate degrees from Duke University and a doctorate degree from George Washington University.